D5BH Stock Overview
Xtrackers MSCI Canada ESG Screened UCITS ETF is an exchange-traded fund launched by Deutsche Asset Management S.A.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Xtrackers MSCI Canada ESG Screened UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$70.97 |
52 Week High | US$71.92 |
52 Week Low | US$58.48 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 3.32% |
1 Year Change | 9.66% |
3 Year Change | 22.57% |
5 Year Change | 52.69% |
Change since IPO | 107.82% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
D5BH | DE Capital Markets | DE Market | |
---|---|---|---|
7D | 2.1% | 2.0% | -0.3% |
1Y | 9.7% | 23.3% | 2.8% |
Return vs Industry: D5BH underperformed the German Capital Markets industry which returned 23.3% over the past year.
Return vs Market: D5BH exceeded the German Market which returned 2.8% over the past year.
Price Volatility
D5BH volatility | |
---|---|
D5BH Average Weekly Movement | 1.6% |
Capital Markets Industry Average Movement | 4.7% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: D5BH has not had significant price volatility in the past 3 months.
Volatility Over Time: D5BH's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | n/a | etf.dws.com/LUX/ENG/ETF/LU0476289540/-/MSCI-Canada-Index-UCITS-ETF |
Xtrackers MSCI Canada ESG Screened UCITS ETF is an exchange-traded fund launched by Deutsche Asset Management S.A. The fund is co-managed by Deutsche Asset Management Investment GmbH and Deutsche Asset Management (UK) Limited. It invests in the public equity markets of Canada.
Xtrackers MSCI Canada ESG Screened UCITS ETF Fundamentals Summary
D5BH fundamental statistics | |
---|---|
Market cap | €326.11m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs D5BH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
D5BH income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did D5BH perform over the long term?
See historical performance and comparison